UBS has increased its price target for CAVA to $69, reflecting a slightly more optimistic outlook, although the firm maintains a neutral rating on the stock. This adjustment suggests a balanced view of CAVA's potential, which traders should consider when evaluating the stock. The average rating for CAVA is overweight, with a mean price target of $73.52, indicating a generally positive sentiment from other analysts. Access to the full analysis requires a premium subscription, so traders should seek out other sources for more detailed insights.